Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Tallal Hussein Younis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 6 Finished
-
Dissemination, implementation, and effectiveness of the exercise oncology survivorship partnership model: reaching rural cancer survivors to enhance quality of life
Culos-reed, S. N. S. N. (PI), Abraham Joy, A. A. (CoPI), Alibhai, S. S. (CoPI), Blanchard, C. M. (CoPI), Bouchard, D. D. (CoPI), Campbell, K. K. (CoPI), Capozzi, L. L. (CoPI), Chamorro- Vina, C. G. (CoPI), Cuthbert, C. C. (CoPI), Eisenstat, D. D. D. D. (CoPI), Francis, G. G. (CoPI), Giacomantonio, N. B. (CoPI), Grandy, S. S. (CoPI), Hill, L. L. (CoPI), Keats, M. R. (CoPI), Langelier, D. M. D. M. (CoPI), Manzara, P. P. (CoPI), Mcgowan, E. L. E. L. (CoPI), Mckillop, S. S. (CoPI), Mcneely, M. M. (CoPI), Morris, P. P. (CoPI), Pathak, S. S. (CoPI), Purcell, J. J. (CoPI), Rajda, M. M. (CoPI), Rutledge, R. D. H. (CoPI), Santa Mina, D. D. (CoPI), Saunders, T. J. T. J. (CoPI), Snow, S. L. S. L. (CoPI), Urquhart, R. L. (CoPI), Wilson, B. B. (CoPI), Wood, L. L. (CoPI) & Younis, T. H. (CoPI)
Canadian Cancer Society Research Institute
12/1/19 → 11/30/24
Project: Research project
-
EXercise to prevent AnthraCycline-based Cardio-Toxicity (EXACT 2.0) in individuals with breast cancer
Grandy, S. S. (PI), Blanchard, C. M. (CoPI), Giacomantonio, N. B. (CoPI), Jassal, D. D. (CoPI), Keats, M. R. (CoPI), Nguyen, T. T. (CoPI), Rajda, M. M. (CoPI) & Younis, T. H. (CoPI)
Canadian Cancer Society Research Institute
8/1/18 → 7/31/20
Project: Research project
-
Molecular hallmarks of breast cancer sensitivity to ErbB2-targeted therapies
Rosen, K. V. K. (PI), Bethune, G. G. (CoPI), Rak, J. (CoPI) & Younis, T. H. (CoPI)
4/1/18 → 3/31/23
Project: Research project
-
Cost-Utility of Adjuvant Zoledronic Acid in Breast Cancer
Younis, T. H. (PI) & Rayson, D. D. (CoPI)
Canadian Cancer Society Research Institute
7/1/13 → 6/30/14
Project: Research project
-
Breast canceR Environmental Activity correlateS Trial (BREAST)
Blanchard, C. C. (PI), Keats, M. R. (CoPI), Rainham, D. G. C. (CoPI) & Younis, T. H. (CoPI)
Canadian Cancer Society Research Institute
7/1/12 → 6/30/15
Project: Research project
-
Nurse navigators’ views on patient and system factors associated with navigation needs among women with breast cancer
Miller, S. D., Urquhart, R., Kephart, G., Asada, Y. & Younis, T., 2021, In: Current Oncology. 28, 3, p. 2107-2114 8 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Tumor levels of the mediators of ErbB2-driven anoikis resistance correlate with breast cancer relapse in patients receiving trastuzumab-based therapies
Surette, A., Yoo, B. H., Younis, T., Matheson, K., Rameh, T., Snowdon, J., Bethune, G. & Rosen, K. V., Jun 2021, In: Breast Cancer Research and Treatment. 187, 3, p. 743-758 16 p.Research output: Contribution to journal › Article › peer-review
9 Citations (Scopus) -
Correction to: Trastuzumab-induced upregulation of a protein set in extracellular vesicles emitted by ErbB2-positive breast cancer cells correlates with their trastuzumab sensitivity (Breast Cancer Research, (2020), 22, 1, (105), 10.1186/s13058-020-01342-2)
Drucker, A., Yoo, B. H., Khan, I. A., Choi, D., Montermini, L., Liu, X., Jovanovic, S., Younis, T. & Rosen, K. V., Dec 1 2020, In: Breast Cancer Research. 22, 1, 110.Research output: Contribution to journal › Comment/debate › peer-review
Open Access1 Citation (Scopus) -
Economic evaluation of adjuvant trastuzumab emtansine in patients with her2-positive early breast cancer and residual invasive disease after neoadjuvant taxane and trastuzumab–based treatment in Canada
Younis, T., Lee, A., Coombes, M. E., Bouganim, N., Becker, D., Revil, C. & Jhuti, G. S., Dec 2020, In: Current Oncology. 27, 6, p. 578-589 12 p.Research output: Contribution to journal › Article › peer-review
Open Access9 Citations (Scopus) -
Trastuzumab-induced upregulation of a protein set in extracellular vesicles emitted by ErbB2-positive breast cancer cells correlates with their trastuzumab sensitivity
Durcker, A., Yoo, B. H., Khan, I. A., Choi, D., Montermini, L., Liu, X., Jovanovic, S., Younis, T. & Rosen, K. V., Oct 6 2020, In: Breast Cancer Research. 22, 1, 105.Research output: Contribution to journal › Article › peer-review
Open Access14 Citations (Scopus)